{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:05:58Z","timestamp":1792497958748,"version":"4.5.0"},"reference-count":116,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Serotonergic psychedelics are re-emerging as potential novel treatments for several psychiatric disorders including major depressive disorder. The Canadian Network for Mood and Anxiety Treatments (CANMAT) convened a task force to review the evidence and provide a consensus recommendation for the clinical use of psychedelic treatments for major depressive disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted to identify contemporary clinical trials of serotonergic psychedelics for the treatment of major depressive disorder and cancer-related depression. Studies published between January 1990 and July 2021 were identified using combinations of search terms, inspection of bibliographies and review of other psychedelic reviews and consensus statements. The levels of evidence for efficacy were graded according to the Canadian Network for Mood and Anxiety Treatments criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only psilocybin and ayahuasca have contemporary clinical trials evaluating antidepressant effects. Two pilot studies showed preliminary positive effects of single-dose ayahuasca for treatment-resistant depression (Level 3 evidence). Small randomized controlled trials of psilocybin combined with psychotherapy showed superiority to waitlist controls and comparable efficacy and safety to an active comparator (escitalopram with supportive psychotherapy) in major depressive disorder, with additional randomized controlled trials showing efficacy specifically in cancer-related depression (Level 3 evidence). There was only one open-label trial of psilocybin in treatment-resistant unipolar depression (Level 4 evidence). Small sample sizes and functional unblinding were major limitations in all studies. Adverse events associated with psychedelics, including psychological (e.g., psychotomimetic effects) and physical (e.g., nausea, emesis and headaches) effects, were generally transient.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There is currently only low-level evidence to support the efficacy and safety of psychedelics for major depressive disorder. In Canada, as of 2022, psilocybin remains an experimental option that is only available through clinical trials or the special access program. As such, Canadian Network for Mood and Anxiety Treatments considers psilocybin an experimental treatment and recommends its use primarily within clinical trials, or, less commonly, through the special access program in rare, special circumstances.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/07067437221111371","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T03:45:23Z","timestamp":1660707923000},"page":"5-21","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":61,"title":["The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder"],"prefix":"10.1177","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4773-2191","authenticated-orcid":false,"given":"Joshua D.","family":"Rosenblat","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Ishrat","family":"Husain","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-1580","authenticated-orcid":false,"given":"David","family":"Castle","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Offman","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Depression Program, Michigan Medicine, University of Michigan, Ann Arbor, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benicio N.","family":"Frey","sequence":"additional","affiliation":[{"name":"Mood Disorders Program, St. Joseph's Healthcare Hamilton, McMaster University, Psychiatry & Behavioural Neurosciences, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal","family":"Schaffer","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle T.","family":"Greenway","sequence":"additional","affiliation":[{"name":"McGill University, Psychiatry, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4031-9943","authenticated-orcid":false,"given":"Nicolas","family":"Garel","sequence":"additional","affiliation":[{"name":"McGill University, Psychiatry, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-3870","authenticated-orcid":false,"given":"Serge","family":"Beaulieu","sequence":"additional","affiliation":[{"name":"McGill University, Psychiatry, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-4669","authenticated-orcid":false,"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Providence Care, Queen's University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1655-2753","authenticated-orcid":false,"given":"Arun V.","family":"Ravindran","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2264-9586","authenticated-orcid":false,"given":"Valerie","family":"Tourjman","sequence":"additional","affiliation":[{"name":"Institut universitaire en sant\u00e9 mentale de Montr\u00e9al, Psychiatry, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Van","family":"Ameringen","sequence":"additional","affiliation":[{"name":"McMaster University Medical Centre, Anxiety Disorders Clinic, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi N.","family":"Yatham","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Taylor","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"bibr1-07067437221111371","unstructured":"WHO. World Health Organization (WHO) Depression Fact Sheet."},{"key":"bibr2-07067437221111371","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001547","volume":"10","author":"Ferrari AJ","year":"2013","journal-title":"PLoS Med."},{"key":"bibr3-07067437221111371","first-page":"601439","author":"Gaynes BN","year":"2009","journal-title":"Psychiatric Services (Washington, DC)"},{"key":"bibr4-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659417"},{"key":"bibr5-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716659418"},{"key":"bibr6-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0706743716660033"},{"key":"bibr7-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1055\/a-1310-3990"},{"key":"bibr8-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.11.028"},{"key":"bibr9-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.19010035"},{"key":"bibr10-07067437221111371","unstructured":"COMPASS Pathways receives FDA Breakthrough Therapy designation for psilocybin therapy for treatment-resistant depression | Compass Pathways. https:\/\/compasspathways.com\/https:\/\/compasspathways.com\/compass-pathways-receives-fda-breakthrough-therapy-designation-for-psilocybin-therapy-for-treatment-resistant-depression\/ (accessed May 9, 2022)."},{"key":"bibr11-07067437221111371","unstructured":"Research.\n                      Usona Institute\n                      https:\/\/www.usonainstitute.org\/research\/ (accessed May 9, 2022)."},{"key":"bibr12-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093587"},{"key":"bibr13-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2020.1826931"},{"key":"bibr14-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0706743720970860"},{"key":"bibr15-07067437221111371","author":"Tourjman SV","journal-title":"Can J Psychiatry (in revision)"},{"key":"bibr16-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.12609"},{"key":"bibr17-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1111\/bdi.13135"},{"key":"bibr18-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1124\/pr.115.011478"},{"key":"bibr19-07067437221111371","first-page":"131","volume":"119","author":"Glennon RA","year":"1992","journal-title":"NIDA Res Monogr"},{"key":"bibr20-07067437221111371","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080793"},{"key":"bibr21-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120986422"},{"key":"bibr22-07067437221111371","first-page":"108:423","author":"Dos Santos RG","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"bibr23-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119895520"},{"key":"bibr24-07067437221111371","first-page":"136:443","author":"Arango V","year":"2002","journal-title":"Prog Brain Res."},{"key":"bibr25-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.8.705"},{"key":"bibr26-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.109.069567"},{"key":"bibr27-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2013.05.029"},{"key":"bibr28-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.120.000056"},{"key":"bibr29-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1481827"},{"key":"bibr30-07067437221111371","first-page":"986:76","author":"Raichle ME","year":"2001","journal-title":"Proc Natl Acad Sci U S A."},{"key":"bibr31-07067437221111371","volume":"8","author":"Carhart-Harris RL","year":"2014","journal-title":"Front Hum Neurosci"},{"key":"bibr32-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881110367445"},{"key":"bibr33-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000000436"},{"key":"bibr34-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73216-8"},{"issue":"3","key":"bibr35-07067437221111371","first-page":"677","volume":"68","author":"Grinspoon L","year":"2001","journal-title":"Soc Res (New York)."},{"key":"bibr36-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119855974"},{"key":"bibr37-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.23234"},{"key":"bibr38-07067437221111371","first-page":"197:83","author":"Johnson MW","year":"2019","journal-title":"Pharmacol Ther"},{"key":"bibr39-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675513"},{"key":"bibr40-07067437221111371","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26102948"},{"key":"bibr41-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2021.1933434"},{"key":"bibr42-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05464-5"},{"key":"bibr43-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01524-1"},{"key":"bibr44-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.19030077"},{"key":"bibr45-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25387"},{"key":"bibr46-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3458-05.2005"},{"key":"bibr47-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1192\/apt.12.4.287"},{"key":"bibr48-07067437221111371","first-page":"139:85","author":"Enck P","year":"2018","journal-title":"Int Rev Neurobiol"},{"key":"bibr49-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01397-3"},{"key":"bibr50-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1659-20.2020"},{"key":"bibr51-07067437221111371","doi-asserted-by":"publisher","DOI":"10.2174\/1874467211666181010154139"},{"key":"bibr52-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.049882"},{"key":"bibr53-07067437221111371","doi-asserted-by":"publisher","DOI":"10.3390\/ph13110334"},{"key":"bibr54-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6865(97)00014-9"},{"key":"bibr55-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1640-6"},{"key":"bibr56-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119598109"},{"key":"bibr57-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyv072"},{"key":"bibr58-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0513-9"},{"key":"bibr59-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196455611"},{"key":"bibr60-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1002\/dta.2821"},{"key":"bibr61-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950020009001"},{"key":"bibr62-07067437221111371","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20ac13786"},{"key":"bibr63-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-8741(98)00168-8"},{"key":"bibr64-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427703"},{"key":"bibr65-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.05.019"},{"key":"bibr66-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(16)30065-7"},{"key":"bibr67-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032994"},{"key":"bibr68-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"bibr69-07067437221111371","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62878","volume":"10","author":"Szigeti B","year":"2021","journal-title":"eLife"},{"key":"bibr70-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-017-4771-x"},{"key":"bibr71-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2020.3285"},{"key":"bibr72-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/02698811211073759"},{"key":"bibr73-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05719-1"},{"key":"bibr74-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119897615"},{"key":"bibr75-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1080\/09540261.2018.1482261"},{"key":"bibr76-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116675512"},{"key":"bibr77-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2014-1496"},{"key":"bibr78-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05692-9"},{"key":"bibr79-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001356"},{"key":"bibr80-07067437221111371","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01325","volume":"10","author":"Zeifman RJ","year":"2019","journal-title":"Front Pharmacol"},{"key":"bibr81-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2020.1737763"},{"key":"bibr82-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psychotherapy.20200055"},{"key":"bibr83-07067437221111371","volume":"8","author":"Barrett FS","year":"2017","journal-title":"Front Psychol"},{"key":"bibr84-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.0c00187"},{"key":"bibr85-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-05876-x"},{"key":"bibr86-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2487"},{"key":"bibr87-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2021.03.013"},{"key":"bibr88-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1055\/a-1524-2794"},{"issue":"4","key":"bibr89-07067437221111371","first-page":"252","volume":"29","author":"Celada P","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"bibr90-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-021-06049-6"},{"key":"bibr91-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/0269881111420188"},{"key":"bibr92-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022489118"},{"key":"bibr93-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1021\/acsptsci.1c00024"},{"key":"bibr94-07067437221111371","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112532","volume":"239","author":"Fotiou E","year":"2019","journal-title":"Soc Sci Med"},{"key":"bibr95-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00421-7"},{"key":"bibr96-07067437221111371","first-page":"113:179","author":"Aday JS","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"bibr97-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60464-4"},{"key":"bibr98-07067437221111371","unstructured":"A Review of Hallucinogen Persisting Perception Disorder (HPPD) and an Exploratory Study of Subjects Claiming Symptoms of HPPD | SpringerLinkhttps:\/\/link.springer.com\/chapter\/10.1007\/7854_2016_457 (accessed August 25, 2021)."},{"key":"bibr99-07067437221111371","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci8030047"},{"key":"bibr100-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312451270"},{"key":"bibr101-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-022-06066-z"},{"key":"bibr102-07067437221111371","first-page":"1","volume":"3","author":"Doyle MA","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"bibr103-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1962.03050280091013b"},{"key":"bibr104-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196711162772001"},{"key":"bibr105-07067437221111371","unstructured":"Branch LS. Consolidated federal laws of Canada, Controlled Drugs and Substances Acthttps:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-38.8\/page-12.html (2021, accessed August 25, 2021)."},{"key":"bibr106-07067437221111371","unstructured":"Government of Canada PW and GSC. Canada Gazette, Part 2, Volume 156, Number 1: Regulations Amending Certain Regulations Relating to Restricted Drugs (Special Access Program) https:\/\/www.gazette.gc.ca\/rp-pr\/p2\/2022\/2022-01-05\/html\/sor-dors271-eng.html (2022, accessed January 11, 2022)."},{"key":"bibr107-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.12481"},{"key":"bibr108-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.19366"},{"key":"bibr109-07067437221111371","unstructured":"Canada H. Guidance Document For Clinical Trial Sponsors: Clinical Trial Applicationshttps:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/applications-submissions\/guidance-documents\/clinical-trials\/clinical-trial-sponsors-applications.html (2003, accessed August 25, 2021)."},{"key":"bibr110-07067437221111371","unstructured":"COMPASS Pathways. The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression. Clinical Trial Registration NCT03775200clinicaltrials.gov; https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03775200 (June 28, 2021, accessed September 30, 2021)."},{"key":"bibr111-07067437221111371","unstructured":"Rosenblat JD. The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study. Clinical Trial Registration NCT05029466clinicaltrials.gov;https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05029466 (August 31, 2021, accessed September 30, 2021)."},{"key":"bibr112-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(20)30146-2"},{"key":"bibr113-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00489-1"},{"key":"bibr114-07067437221111371","doi-asserted-by":"crossref","DOI":"10.1186\/s12991-015-0063-1","volume":"14","author":"Dragioti E","year":"2015","journal-title":"Ann Gen Psychiatry"},{"key":"bibr115-07067437221111371","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1964.03060230096025","volume":"187","author":"Grinker RR","year":"1964","journal-title":"JAMA"},{"key":"bibr116-07067437221111371","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1963.01720110001001"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/07067437221111371","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/07067437221111371","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/07067437221111371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:15:00Z","timestamp":1777392900000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/07067437221111371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1177\/07067437221111371"],"URL":"https:\/\/doi.org\/10.1177\/07067437221111371","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]}}}